These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
259 related items for PubMed ID: 17001858
1. [Investigation of autoantibody, anti-HCV and anti-HIV seropositivities in "anti-HBc alone" positive samples]. Meşe S, Ozekinci T, Yilmaz S, Atmaca S, Arikan E. Mikrobiyol Bul; 2006 Jul; 40(3):269-74. PubMed ID: 17001858 [Abstract] [Full Text] [Related]
2. Frequency of isolated hepatitis B core antibody in HIV-hepatitis C virus co-infected individuals. Ramezani A, Mohraz M, Aghakhani A, Banifazl M, Eslamifar A, Khadem-Sadegh A, Velayati AA. Int J STD AIDS; 2009 May; 20(5):336-8. PubMed ID: 19386971 [Abstract] [Full Text] [Related]
3. No evidence of hepatitis B virus activity in patients with anti-HBc antibody positivity with or without anti-hepatitis C virus antibody positivity. Haushofer AC, Hauer R, Brunner H, Köller U, Trubert-Exinger D, Halbmayer WM, Koidl C, Kessler HH. J Clin Virol; 2004 Apr; 29(4):221-3. PubMed ID: 15018848 [Abstract] [Full Text] [Related]
4. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B]. Altindiş M, Uslan I, Cetinkaya Z, Yüksel S, Ciftçi IH, Demirtürk N, Ozdemir M, Arslan F, Aktepe OC. Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709 [Abstract] [Full Text] [Related]
5. Occult hepatitis B virus infection in HIV-infected patients with isolated hepatitis B core antibody. Azadmanesh K, Mohraz M, Aghakhani A, Edalat R, Jam S, Eslamifar A, Banifazl M, Moradmand-Badie B, Ramezani A. Intervirology; 2008 Apr; 51(4):270-4. PubMed ID: 18841029 [Abstract] [Full Text] [Related]
6. Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies. Gandhi RT, Wurcel A, Lee H, McGovern B, Shopis J, Geary M, Sivamurthy R, Sax PE, Ukomadu C. J Infect Dis; 2005 May 01; 191(9):1435-41. PubMed ID: 15809901 [Abstract] [Full Text] [Related]
8. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission. Rai RR, Mathur A, Mathur D, Udawat HP, Nepalia S, Nijhawan S, Mathur A. Trop Gastroenterol; 2007 Sep 01; 28(1):19-23. PubMed ID: 17896605 [Abstract] [Full Text] [Related]
9. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus]. Wu CH, Xu XY, Tian GS, Yu YY. Zhonghua Yi Xue Za Zhi; 2006 Feb 14; 86(6):390-3. PubMed ID: 16677548 [Abstract] [Full Text] [Related]
10. Hepatitis B and hepatitis C prevalence among blood donors and HIV-1 infected patients in Florianópolis--Brazil. Treitinger A, Spada C, Ferreira LA, Neto MS, Reis M, Verdi JC, de Miranda AF, de Oliveira OV, Van der Sander Silveira M, Abdalla DS. Braz J Infect Dis; 2000 Aug 14; 4(4):192-6. PubMed ID: 11008223 [Abstract] [Full Text] [Related]
11. HBV and HCV infection in Japanese dental care workers. Nagao Y, Matsuoka H, Kawaguchi T, Ide T, Sata M. Int J Mol Med; 2008 Jun 14; 21(6):791-9. PubMed ID: 18506374 [Abstract] [Full Text] [Related]
12. Anti-HBc screening in Egyptian blood donors reduces the risk of hepatitis B virus transmission. El-Zayadi AR, Ibrahim EH, Badran HM, Saeid A, Moneib NA, Shemis MA, Abdel-Sattar RM, Ahmady AM, El-Nakeeb A. Transfus Med; 2008 Feb 14; 18(1):55-61. PubMed ID: 18279193 [Abstract] [Full Text] [Related]
13. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice. Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E. Transfusion; 2007 Jan 14; 47(1):74-9. PubMed ID: 17207233 [Abstract] [Full Text] [Related]
14. [High percentage of isolated anti-HBc-positive persons among prisoners]. Neifer S, Molz B, Sucker U, Kreuzpaintner E, Weinberger K, Jilg W. Gesundheitswesen; 1997 Jun 14; 59(6):409-12. PubMed ID: 9333377 [Abstract] [Full Text] [Related]
15. Occult hepatitis B in HIV-HCV coinfected patients. Piroth L, Lafon ME, Binquet C, Bertillon P, Gervais A, Lootvoet E, Lang JM, De Jaureguiberry JP, Chene G, Leport C, ANRS CO8 APROCO-COPILOTE Study Group. Scand J Infect Dis; 2008 Jun 14; 40(10):835-9. PubMed ID: 18609222 [Abstract] [Full Text] [Related]
16. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus. Adachi S, Shibuya A, Miura Y, Takeuchi A, Nakazawa T, Saigenji K. Scand J Gastroenterol; 2008 Jun 14; 43(7):849-56. PubMed ID: 18584524 [Abstract] [Full Text] [Related]
17. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients. Yakaryilmaz F, Gurbuz OA, Guliter S, Mert A, Songur Y, Karakan T, Keles H. Ren Fail; 2006 Jun 14; 28(8):729-35. PubMed ID: 17162434 [Abstract] [Full Text] [Related]
18. [Detection of hepatitis B and hepatitis C markers in HIV positive patients, 2000-2004]. Bello Corredor M, Rodríguez Lay Lde L, Gutiérrez Moreno A, Sariego Frómeta S, Montalvo Villalba MC, Sánchez Sol A. Rev Cubana Med Trop; 2005 Jun 14; 57(3):212-3. PubMed ID: 17969276 [Abstract] [Full Text] [Related]
19. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem? Rodríguez-Torres M, Gonzalez-Garcia J, Bräu N, Solá R, Moreno S, Rockstroh J, Smaill F, Mendes-Correa MC, DePamphilis J, Torriani FJ, APRICOT Investigators. J Med Virol; 2007 Jun 14; 79(6):694-700. PubMed ID: 17457912 [Abstract] [Full Text] [Related]
20. Antibody to hepatitis B core antigen is associated with the development of hepatocellular carcinoma in hepatitis C virus-infected persons: a 12-year prospective study. Tanaka K, Nagao Y, Ide T, Kumashiro R, Sata M. Int J Mol Med; 2006 May 14; 17(5):827-32. PubMed ID: 16596267 [Abstract] [Full Text] [Related] Page: [Next] [New Search]